Literature DB >> 23993067

Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.

Hari M Polenakovik1, Craig M Pleiman.   

Abstract

Data regarding ceftaroline use for meticillin-resistant Staphylococcus aureus bacteraemia (MRSAB) are lacking. Here we review the outcomes of 31 patients with MRSAB treated with ceftaroline, including 9 patients with endocarditis. Clinical success was observed in 23 patients (74.2%). Adverse events associated with prolonged therapy were rare and included eosinophilic pneumonia, rash and diarrhoea. We conclude that ceftaroline can be used for MRSAB.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Bacteraemia; Ceftaroline; Endocarditis; MRSA; Meticillin-resistant Staphylococcus aureus

Mesh：

Substances：

Year:  2013        PMID： 23993067     DOI： 10.1016/j.ijantimicag.2013.07.005

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


  12 in total

1.  Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  James Truong; John J Veillette; Steve C Forland
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 2.  Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.

Authors:  Nicholas A Turner; Batu K Sharma-Kuinkel; Stacey A Maskarinec; Emily M Eichenberger; Pratik P Shah; Manuela Carugati; Thomas L Holland; Vance G Fowler
Journal:  Nat Rev Microbiol       Date:  2019-04       Impact factor: 60.633

3.  Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Authors:  Evan J Zasowski; Trang D Trinh; Kimberly C Claeys; Anthony M Casapao; Noor Sabagha; Abdalhamid M Lagnf; Kenneth P Klinker; Susan L Davis; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Ceftaroline Cerebrospinal Fluid Penetration in the Treatment of a Ventriculopleural Shunt Infection: A Case Report.

Authors:  Jeffrey J Cies; Wayne S Moore; Adela Enache; Arun Chopra
Journal:  J Pediatr Pharmacol Ther       Date:  2020

Review 5.  The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Authors:  Kyle C Molina; Taylor Morrisette; Matthew A Miller; Vanthida Huang; Douglas N Fish
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 6.  Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.

Authors:  Sanjiv M Baxi; Dominic Chan; Vivek Jain
Journal:  Infection       Date:  2015-03-25       Impact factor: 3.553

7.  Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.

Authors:  Henry F Chambers; Li Basuino; Stephanie M Hamilton; Eun Ju Choo; Pamela Moise
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

8.  Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis.

Authors:  Valeria Fabre; Marcela Ferrada; Whitney R Buckel; Edina Avdic; Sara E Cosgrove
Journal:  Open Forum Infect Dis       Date:  2014-07-08       Impact factor: 3.835

Review 9.  Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review.

Authors:  Reese A Cosimi; Nahal Beik; David W Kubiak; Jennifer A Johnson
Journal:  Open Forum Infect Dis       Date:  2017-05-02       Impact factor: 3.835

10.  Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid and Mitral Valve Methicillin-Resistant Staphylococcus aureus Endocarditis.

Authors:  Hadeel Zainah; Marcus Zervos; Wassim Stephane; Sara Chamas Alhelo; Ghattas Alkhoury; Allison Weinmann
Journal:  Case Rep Infect Dis       Date:  2013-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.